Rhumbline Advisers Viatris Inc Transaction History

Rhumbline Advisers

$104 Billion
Q1 2025

A detailed history of Rhumbline Advisers transactions in Viatris Inc stock. As of the latest transaction made, Rhumbline Advisers holds 3,239,234 shares of VTRS stock, worth $24.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,239,234

Previous 2,867,224 12.97%

Holding current value

$24.5 Million

Previous $35.7 Million 20.96%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 08, 2025	BUY	$8.68 - $12.42 $3.23 Million - $4.62 Million	372,010 Added 12.97%	3,239,234 $28.2 Million
Q4 2024 Jan 30, 2025	BUY	$11.32 - $13.37 $1.36 Million - $1.61 Million	120,443 Added 4.38%	2,867,224 $35.7 Million
Q3 2024 Nov 12, 2024	BUY	$10.32 - $12.13 $6.74 Million - $7.92 Million	652,939 Added 31.18%	2,746,781 $31.9 Million
Q2 2024 Aug 01, 2024	SELL	$10.05 - $12.02 $111,132 - $132,917	-11,058 Reduced 0.53%	2,093,842 $22.3 Million
Q1 2024 May 09, 2024	SELL	$11.27 - $13.53 $83,420 - $100,149	-7,402 Reduced 0.35%	2,104,900 $25.1 Million
Q4 2023 Feb 08, 2024	SELL	$8.77 - $10.85 $336,303 - $416,064	-38,347 Reduced 1.78%	2,112,302 $22.9 Million
Q3 2023 Nov 09, 2023	SELL	$9.59 - $11.35 $441,830 - $522,917	-46,072 Reduced 2.1%	2,150,649 $21.2 Million
Q2 2023 Aug 08, 2023	SELL	$9.02 - $10.29 $484,617 - $552,850	-53,727 Reduced 2.39%	2,196,721 $21.9 Million
Q1 2023 May 11, 2023	BUY	$9.2 - $12.26 $516,276 - $687,994	56,117 Added 2.56%	2,250,448 $21.6 Million
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $509,657 - $675,647	58,447 Added 2.74%	2,194,331 $24.4 Million
Q3 2022 Nov 10, 2022	BUY	$8.48 - $11.13 $855,589 - $1.12 Million	100,895 Added 4.96%	2,135,884 $18.2 Million
Q2 2022 Aug 11, 2022	BUY	$9.95 - $12.27 $2.28 Million - $2.81 Million	229,067 Added 12.68%	2,034,989 $21.3 Million
Q1 2022 May 12, 2022	BUY	$9.81 - $15.4 $1.08 Million - $1.69 Million	110,000 Added 6.49%	1,805,922 $19.6 Million
Q4 2021 Feb 10, 2022	BUY	$12.09 - $14.68 $223,483 - $271,359	18,485 Added 1.1%	1,695,922 $22.9 Million
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $818,585 - $934,731	-61,780 Reduced 3.55%	1,677,437 $22.7 Million
Q2 2021 Aug 05, 2021	SELL	$12.97 - $16.15 $728,252 - $906,806	-56,149 Reduced 3.13%	1,739,217 $24.9 Million
Q1 2021 May 06, 2021	SELL	$13.59 - $18.54 $1.39 Million - $1.9 Million	-102,563 Reduced 5.4%	1,795,366 $25.1 Million
Q4 2020 Feb 10, 2021	BUY	$14.3 - $18.74 $27.1 Million - $35.6 Million	1,897,929 New	1,897,929 $35.6 Million

Others Institutions Holding VTRS

# of Institutions

1,137

Shares Held

989M

Call Options Held

2.34M

Put Options Held

2.21M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $9.17B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Viatris Inc Transaction History